Skip to content

Net Change in Cash at other companies

Pfizer logo
PfizerPFE
$563M+50.1%
ArriVent BioPharma, Inc. logo
ArriVent BioPharma, Inc.AVBP
$16.56M+168%
CG Oncology logo
CG OncologyCGON
$1.21M+101%
Olema Pharmaceuticals, Inc. logo
Olema Pharmaceuticals, Inc.OLMA
$4.25M+105%
Inhibrx Biosciences, Inc. logo
Inhibrx Biosciences, Inc.INBX
$37.44M-41.4%
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
$74.44M-49.3%

Other financials

Income statement

See full
Operating income-$39.6M-21.1%
Net income-$35.8M-19.1%
EPS (diluted)-$0.34+19.0%

Balance sheet

See full
Cash & equivalents$56.4M+14.3%
Total debt$3.3M+2.6%
Total equity$415.6M+89.1%
Total assets$436.8M+79.8%

Cash flow

See full
Operating cash flow-$32.4M+0.3%
CapEx$2.0K-99.5%
Free cash flow-$32.4M+1.5%

Valuation

See full
Market cap$976.17M+23.0%
Enterprise value$923.07M+23.5%

Returns & leverage

See full
Return on equity-42.6%-4.6pp
Debt / equity0.0×
Current ratio16.3×+4.3×

Where this comes from

Reported directly by Oric Pharmaceuticals, Inc. in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.

The official record: Oric Pharmaceuticals, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Oric Pharmaceuticals, Inc.'s net change in cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Oric Pharmaceuticals, Inc.'s net change in cash?
Oric Pharmaceuticals, Inc. (ORIC) reported net change in cash of $10.73M in Q1 2026.
How has Oric Pharmaceuticals, Inc.'s net change in cash changed year-over-year?
Oric Pharmaceuticals, Inc.'s net change in cash increased by 206.5% year-over-year, from -$10.07M to $10.73M.
What does net change in cash mean?
Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.